Home / Health / New Jab, Pill May Curb Cravings
New Jab, Pill May Curb Cravings
6 Jul
Summary
- Semaglutide drug mimics a natural hormone to control appetite.
- Common side effects include nausea, vomiting, and constipation.
- Consult a doctor for medical history and potential risks.
A new semaglutide medication, available as both an injection and a pill, is designed to help manage appetite. This drug mimics the action of a natural hormone, glucagon-like-peptide-1 (GPL-1), which is released after eating.
The medication works by targeting appetite control receptors in the brain. This can lead to increased feelings of fullness, reduced hunger, and fewer food cravings. Patients often report feeling satisfied with less food.
Common side effects associated with both the jab and pill include gastrointestinal issues such as nausea, vomiting, constipation, and diarrhea. Some individuals may experience localized reactions at the injection site, including redness, itching, or mild swelling.
Less frequent side effects can involve stomach pain, headaches, and tiredness. In rarer cases, more serious complications like low blood sugar, pancreatitis, or severe allergic reactions may occur. It is essential to review the patient information leaflet for a comprehensive list of effects.
Individuals under 18, pregnant, or breastfeeding should not take this medication. A thorough discussion with a doctor is necessary to address any existing medical conditions or concurrent medications.
